Latest Articles
A novel tRNA-derived fragment, tRF-19-79MP9PJZ, promotes uterine corpus endometrial carcinoma progression by targeting DSC3.
Uterine corpus endometrial carcinoma (UCEC) ranks as the 6th most common malignancy among women. Emerging evidence indicates that the dysregulation of tRNA-derived fragments (tRFs) is involved in the pathogenesis of …
Published: Aug. 6, 2026, midnight
Risk of Concurrent Endometrial Carcinoma in Patients Diagnosed With Atypical Endometrial Hyperplasia: A Retrospective Observational Study - Cureus
Risk of Concurrent Endometrial Carcinoma in Patients Diagnosed With Atypical Endometrial Hyperplasia: A Retrospective Observational Study Cureus
Published: July 5, 2026, 4:45 a.m.
Cholesteryl Ester Accumulation as a Biomarker for Personalized Selection of Fertility-Preserving Therapies in Endometrioid Endometrial Carcinoma - EurekAlert!
Cholesteryl Ester Accumulation as a Biomarker for Personalized Selection of Fertility-Preserving Therapies in Endometrioid Endometrial Carcinoma EurekAlert!
Published: June 22, 2026, 7:37 p.m.
The significance of retroperitoneal lymph node dissection in stage 1 endometrial carcinoma: A... - Medical Dialogues
The significance of retroperitoneal lymph node dissection in stage 1 endometrial carcinoma: A... Medical Dialogues
Published: June 22, 2026, 5:15 a.m.
Epithelial-Mesenchymal Transitional Markers in Endometrial Carcinoma: A Review of Clinicopathological Correlation - Cureus
Epithelial-Mesenchymal Transitional Markers in Endometrial Carcinoma: A Review of Clinicopathological Correlation Cureus
Published: June 11, 2026, 8:19 a.m.
Analysis of Tumor-Associated Macrophages (TAM) Using Cluster of Differentiation 68 (CD68) Immunohistochemical Marker in Endometrial Carcinoma - Cureus
Analysis of Tumor-Associated Macrophages (TAM) Using Cluster of Differentiation 68 (CD68) Immunohistochemical Marker in Endometrial Carcinoma Cureus
Published: May 31, 2026, 4:44 p.m.
Dual PI3K/AKT/mTOR and CDK4/6 inhibition suppresses survivin to overcome uterine dedifferentiated endometrial carcinoma - Nature
Dual PI3K/AKT/mTOR and CDK4/6 inhibition suppresses survivin to overcome uterine dedifferentiated endometrial carcinoma Nature
Published: May 8, 2026, 3:28 p.m.
Delayed Chylothorax After Endometrial Carcinoma: A Case of Confirmed Thoracic Duct Leak Successfully Managed Conservatively - Cureus
Delayed Chylothorax After Endometrial Carcinoma: A Case of Confirmed Thoracic Duct Leak Successfully Managed Conservatively Cureus
Published: May 6, 2026, 9:16 a.m.
Evaluation of Ki-67 Expression in Disordered Proliferative Endometrium, Endometrial Hyperplasia, and Endometrial Carcinoma - Cureus
Evaluation of Ki-67 Expression in Disordered Proliferative Endometrium, Endometrial Hyperplasia, and Endometrial Carcinoma Cureus
Published: April 28, 2026, 10:12 a.m.
Abemaciclib Plus Letrozole Shows Activity in Endometrial Carcinoma - Oncology Nursing News
Abemaciclib Plus Letrozole Shows Activity in Endometrial Carcinoma Oncology Nursing News
Published: April 15, 2026, 4:59 p.m.
Link copied to clipboard!